FDA
FDA-approved eye drop ‘paradigm shift’ for presbyopia patients
A new, “first-of-its kind” presbyopia drop will soon be available in the US after the Food and Drug Administration (FDA)...
Read moreDetails
Strong Aussie link to breakthrough in treatment of MacTel, FDA approval
A biotech breakthrough with a strong Australian link will be giving about 25,000 people Down Under a little more hope....
Read moreDetails
Gene therapy improves vision in legally blind children
A gene therapy developed by scientists in the UK has been granted orphan drug designation by the US FDA and...
Read moreDetails
Bayer’s aflibercept 8 mg recommended for approval in EU
Bayer’s higher dose aflibercept 8 mg with extended treatment intervals is set for approval in the European Union (EU) for...
Read moreDetails
FDA updates warning for contaminated eyedrop products
The US Food and Drug Administration (FDA) has issued product warnings for an additional 27 over-the-counter eyedrop products due to...
Read moreDetails
FDA clears higher dose Eylea; approvals sought in other markets
The US FDA has approved the use of high dose Eylea (aflibercept) for three macular conditions, equating to longer intravitreal...
Read moreDetails
FDA approves Iveric Bio’s IZERVAY for geographic atrophy
The US Food and Drug Administration (FDA) has approved a second therapy for geographic atrophy (GA), with IZERVAY (avacincaptad pegol...
Read moreDetailsFDA approves Apellis’ SYFOVRE for first geographic atrophy treatment
In a historic first, the US Food and Drug Administration (FDA) has approved SYFOVRE (pegcetacoplan injection), manufactured by global biopharmaceutical...
Read moreDetails